Bridging the Gap Between Participants and Clinical Trials

CPX101-Ⅱ-01 Obese Subjects without Diabetes Mellitus

CONDITION

Metabolic and Endocrine

GENDER

All

AGE GROUP

From 18

to 75 years

STATUS

Completed

A Randomized, Double-blind, Placebo-controlled, Parallel-group Multicenter Trial to Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects without Diabetes Mellitus

Studies Contact Form

Name*
First Last
Email*
Phone Number
Message*
CAPTCHA
- Send me updates about clinical trials
All
- All

Approved By: Bellberry limited

Clinical Trial Registry Link: